27248327|t|Expression and functional characterization of CD33 transcript variants in human acute myeloid leukemia.
27248327|a|With the demonstration of improved survival of some acute myeloid leukemia (AML) patients with the CD33 antibody-drug conjugate, gemtuzumab ozogamicin (GO), CD33 has been validated as a target for antigen-specific immunotherapy. Since previous studies identified a CD33 splice variant missing exon 2 (CD33 E2) and, consequently, the immune-dominant membrane-distal V-set domain, we investigated the expression and functional characteristics of CD33 transcript variants in AML. In primary AML specimens, we not only found full-length CD33 (CD33FL) and CD33 E2 but also corresponding variants containing an alternate exon 7 predicted to encode a CD33 protein lacking most of the intracellular domain (CD33E7a and, not previously described, CD33 E2,E7a) in almost all cases. In acute leukemia cell sublines engineered to express individual CD33 splice variants, all splice variants had endocytic properties. CD33FL and CD33E7a mediated similar degrees of GO cytotoxicity, whereas CD33 E2 and CD33 E2,E7a could not serve as target for GO. Co-expression of CD33 E2 did not interfere with CD33FL endocytosis and did not impact CD33FL-mediated GO cytotoxicity. Together, our findings document a greater-than-previously thought complexity of CD33 expression in human AML. They identify CD33 variants that lack exon 2 and are not recognized by current CD33-directed therapeutics as potential target for future unconjugated or conjugated antibodies.
27248327	46	50	CD33	Gene	945
27248327	74	79	human	Species	9606
27248327	80	102	acute myeloid leukemia	Disease	MESH:D015470
27248327	156	178	acute myeloid leukemia	Disease	MESH:D015470
27248327	180	183	AML	Disease	MESH:D015470
27248327	185	193	patients	Species	9606
27248327	203	207	CD33	Gene	945
27248327	233	254	gemtuzumab ozogamicin	Chemical	MESH:D000079982
27248327	256	258	GO	Chemical	MESH:D000079982
27248327	261	265	CD33	Gene	945
27248327	369	373	CD33	Gene	945
27248327	405	409	CD33	Gene	945
27248327	548	552	CD33	Gene	945
27248327	576	579	AML	Disease	MESH:D015470
27248327	592	595	AML	Disease	MESH:D015470
27248327	637	641	CD33	Gene	945
27248327	643	649	CD33FL	Gene	945
27248327	655	659	CD33	Gene	945
27248327	748	752	CD33	Gene	945
27248327	842	846	CD33	Gene	945
27248327	879	893	acute leukemia	Disease	MESH:D015470
27248327	941	945	CD33	Gene	945
27248327	1009	1015	CD33FL	Gene	945
27248327	1056	1058	GO	Chemical	MESH:D000079982
27248327	1059	1071	cytotoxicity	Disease	MESH:D064420
27248327	1081	1085	CD33	Gene	945
27248327	1093	1097	CD33	Gene	945
27248327	1135	1137	GO	Chemical	MESH:D000079982
27248327	1156	1160	CD33	Gene	945
27248327	1187	1193	CD33FL	Gene	945
27248327	1225	1231	CD33FL	Gene	945
27248327	1241	1243	GO	Chemical	MESH:D000079982
27248327	1244	1256	cytotoxicity	Disease	MESH:D064420
27248327	1338	1342	CD33	Gene	945
27248327	1357	1362	human	Species	9606
27248327	1363	1366	AML	Disease	MESH:D015470
27248327	1382	1386	CD33	Gene	945
27248327	1447	1451	CD33	Gene	945
27248327	Bind	MESH:D000079982	945
27248327	Association	MESH:D015470	945
27248327	Association	MESH:D064420	945
27248327	Negative_Correlation	MESH:D000079982	MESH:D015470

